Malignant pleural effusion: from bench to bedside

被引:173
|
作者
Psallidas, Ioannis [1 ]
Kalomenidis, Ioannis [2 ]
Porcel, Jose M. [3 ]
Robinson, Bruce W. [4 ,5 ]
Stathopoulos, Georgios T. [6 ,7 ,8 ,9 ]
机构
[1] Oxford Univ Hosp Trust, Oxford Ctr Resp Med, Oxford Resp Trials Unit, Oxford, England
[2] Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care & Pulm Med 1, Athens, Greece
[3] Arnau de Vilanova Univ Hosp, Biomed Res Inst Lleida, Dept Internal Med, Pleural Med Unit, Lleida, Spain
[4] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Perth, WA, Australia
[5] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia
[6] Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Achaia, Greece
[7] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Pneumol Ctr CPC, Munich, Germany
[8] Helmholtz Zentrum Munchen, Munich, Germany
[9] German Ctr Lung Res DZL, Munich, Germany
来源
EUROPEAN RESPIRATORY REVIEW | 2016年 / 25卷 / 140期
基金
欧洲研究理事会;
关键词
MESOTHELIAL CELLS; T-CELLS; DIFFERENTIAL-DIAGNOSIS; LUNG ADENOCARCINOMA; CYTOTOXIC ACTIVITY; TALC PLEURODESIS; MOUSE MODEL; CHEST TUBE; EFFICACY; SURVIVAL;
D O I
10.1183/16000617.0019-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Malignant pleural effusion (MPE) is a common but serious condition that is related with poor quality of life, morbidity and mortality. Its incidence and associated healthcare costs are rising and its management remains palliative, with median survival ranging from 3 to 12 months. During the last decade there has been significant progress in unravelling the pathophysiology of MPE, as well as its diagnostics, imaging, and management. Nowadays, formerly bed-ridden patients are genotyped, phenotyped, and treated on an ambulatory basis. This article attempts to provide a comprehensive overview of current advances in MPE from bench to bedside. In addition, it highlights unanswered questions in current clinical practice and suggests future directions for basic and clinical research in the field.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [31] Management of malignant pleural effusion
    Kacprzak, G
    Kolodziej, J
    Rzechonek, A
    Majewski, A
    Pawlak, I
    Spytkowski, L
    2ND INTERNATIONAL CONGRESS OF THORAX SURGERY, 1998, : 325 - 330
  • [32] Management of Malignant Pleural Effusion
    Jack A. Kastelik
    Lung, 2013, 191 : 165 - 175
  • [33] Management of malignant pleural effusion
    Bravo, JLB
    INTERNATIONAL CONGRESS OF THORAX SURGERY, 1997, : 149 - 155
  • [34] Managing malignant pleural effusion
    Wahla, Ali Saeed
    Uzbeck, Mateen
    Abu El Sameed, Yaser
    Zoumot, Zaid
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2019, 86 (02) : 95 - 99
  • [35] MANAGEMENT OF MALIGNANT PLEURAL EFFUSION
    Navasakulpong, A.
    RESPIROLOGY, 2016, 21 : 5 - 5
  • [36] TREATMENT OF MALIGNANT PLEURAL EFFUSION
    LANE, WZ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 173 (05): : 576 - 576
  • [37] Management of Malignant Pleural Effusion
    Chen, Hongbin
    Brahmer, Julie
    CURRENT ONCOLOGY REPORTS, 2008, 10 (04) : 287 - 293
  • [38] The Treatment of Pleural Carcinosis With Malignant Pleural Effusion
    Ried, Michael
    Hofmann, Hans-Stefan
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (18): : 313 - U25
  • [39] EOSINOPHILIA IN MALIGNANT PLEURAL EFFUSION
    MEHARG, JG
    CHERRY, SA
    ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) : 715 - 715
  • [40] PALLIATION IN MALIGNANT PLEURAL EFFUSION
    JOHNSON, LP
    RIVKIN, SE
    WEBER, EL
    AMERICAN SURGEON, 1975, 41 (09) : 529 - 534